13 days ago
RVMD
AnalystsKelsey GoodwinKelsey Goodwin's Stock Forecasts
AnalystsKelsey Goodwin
Sectors:
Industries:
Analyst Ranking
Top 9%
#432 out of 5213 analysts
Average Return
+47.9%
Win Rate
70%21 out of 30
Risk vs Reward
Poor
Good
Kelsey Goodwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Century Therapeutics IncIPSC | +399.10% | $0.56 | $2.77 | 2025-03-20 - 2026-03-10 | Strong Buy |
Erasca IncERAS | +201.35% | $5.17 | $15.58 | 2026-01-06 - 2026-03-10 | Strong Buy |
Revolution Medicines IncRVMD | +170.55% | $36.54 | $98.86 | 2025-08-18 - 2026-03-10 | Strong Buy |
Genelux CorpGNLX | +147.25% | $3.09 | $7.64 | 2024-10-28 - 2025-10-28 | Strong Buy |
Cg Oncology IncCGON | +145.70% | $25.56 | $62.80 | 2025-08-18 - 2026-03-10 | Strong Buy |
Kelsey Goodwin Analyst Color
Get additional color on Kelsey Goodwin's coverage of popular stocks
2 months ago
TNGX
2 months ago
ERAS
2 months ago
CGON
4 months ago
DAWN
4 months ago
NUVL
Kelsey Goodwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcellx IncACLX | 3 | Hold | $115.00 | +0.53% | Downgrades | 13 days ago |
Revolution Medicines IncRVMD | 2 | Strong Buy | $120.00 | +21.38% | Maintains | 13 days ago |
Tango Therapeutics IncTNGX | 2 | Strong Buy | $14.00 | -15.15% | Maintains | 2 months ago |
Janux Therapeutics IncJANX | 2 | Strong Buy | $30.00 | +113.22% | Maintains | 2 months ago |
Erasca IncERAS | 2 | Strong Buy | $11.00 | -29.40% | Maintains | 2 months ago |
Cg Oncology IncCGON | 2 | Strong Buy | $70.00 | +11.46% | Maintains | 2 months ago |
Black Diamond Therapeutics IncBDTX | 2 | Strong Buy | $8.00 | +252.42% | Maintains | 2 months ago |
Protara Therapeutics IncTARA | 1 | Strong Buy | $24.00 | +320.32% | Initiates Coverage On | 2 months ago |
Oric Pharmaceuticals IncORIC | 1 | Strong Buy | $22.00 | +74.74% | Initiates Coverage On | 2 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $26.00 | +22.18% | Maintains | 4 months ago |
Nuvalent IncNUVL | 4 | Strong Buy | $128.00 | +25.17% | Maintains | 4 months ago |
Summit Therapeutics IncSMMT | 1 | Hold | $21.00 | +28.60% | Initiates Coverage On | 7 months ago |
Urogen Pharma LtdURGN | 3 | Strong Buy | $36.00 | +85.09% | Initiates Coverage On | 7 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $36.00 | +79.46% | Initiates Coverage On | 7 months ago |
Century Therapeutics IncIPSC | 2 | Strong Buy | $5.00 | +80.51% | Maintains | a year ago |
Genelux CorpGNLX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Legend Biotech CorpLEGN | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Iovance Biotherapeutics IncIOVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.